Patient Guide: A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer (mCSPC)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 387 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04497844
Status: ACTIVE_NOT_RECRUITING
Condition: Metastatic Castration-sensitive Prostate Cancer
Phase: PHASE3

Find a Study Location Near You

This study is available at 387 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Homewood, Alabama
  • Phoenix, Arizona
  • Tucson, Arizona
  • • And 384 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily